CS Genetics and ROSALIND® Join Forces to Enhance Genomic Research
Innovative Life Science Partners Aim to Revolutionize the Samples-to-Insight Workflow
CS Genetics, a forward-thinking genomics technology firm, has formed a strategic alliance with ROSALIND®, a leading SaaS platform designed to support life science research. This partnership merges the user-friendly capabilities of CS Genetics' SimpleCell™ platform with the comprehensive multi-omics analysis provided by ROSALIND®. Together, their goal is to significantly improve researchers' access to single-cell technology.
The collaboration promises faster and more efficient insights, enabling scientists to make groundbreaking discoveries at costs that are much lower than those associated with traditional methods.
“At CS Genetics, our creation of the SimpleCell™ platform aims to reshape the economics of single-cell genomics by eliminating the need for costly instrumentation and significantly reducing per-sample expenses,” remarked Jay Harger, Chief Operating Officer at CS Genetics. “By working with ROSALIND®, biopharma and academic teams will have the ability to take on larger and more thorough single-cell projects, while also gaining access to exceptional analytical tools and collaborative capabilities.”
This innovative platform operates without traditional instruments and utilizes Kinetic Confinement technology, making research simpler and scalable. It fits easily into existing laboratory workflows, allowing biopharma and academic researchers to carry out extensive single-cell studies and generate vital insights with impressive speed.
Tim Wesselman, the CEO of ROSALIND®, shared his excitement about the partnership: “We’re thrilled to partner with CS Genetics to overcome significant hurdles in single-cell adoption, such as complexity and cost. SimpleCell™ offers teams unprecedented capabilities to expand their single-cell research, while ROSALIND® enhances their ability to quickly interpret and utilize these discoveries. Together, we aim to accelerate scientific progress while maximizing return on investment by facilitating more projects and empowering larger research teams.”
This collaboration seeks to democratize single-cell genomics, making advanced technologies available to more biopharma companies and academic labs. The objective is to foster greater scientific collaboration and discovery.
About CS Genetics
CS Genetics is a private genomics-technology company with headquarters in Cambridge, UK, and San Diego, California. They have developed a groundbreaking, instrument-free platform for single-cell genomics that delivers remarkable simplicity, speed, and scalability—heralding a new age in next-generation sequencing for cellular analysis. Their technology employs a unique molecular process known as Kinetic Confinement, which distinguishes it from other single-cell technologies and allows for seamless integration into standard laboratory settings. CS Genetics maintains a strong global intellectual property portfolio, covering its single-cell platform, associated reagents, workflow procedures, manufacturing methods, and various application technologies.
About ROSALIND®
ROSALIND is a state-of-the-art cloud-based SaaS platform that empowers life science researchers to analyze, interpret, and collaborate on multi-omic data effortlessly—without requiring coding skills. The platform streamlines the research process, extending from data integration to gleaning actionable insights. By promoting collaboration among diverse teams and technologies, ROSALIND speeds up discoveries in biopharma, academia, and clinical research, emphasizing that a unified platform is crucial for uncovering biological mysteries. The company continues to lead the innovation in areas such as gene expression, single-cell, and spatial biology research.
Contact Information
Shannon Wilsey | CS Genetics PR
For inquiries, please reach out via email.
Frequently Asked Questions
What is the significance of the partnership between CS Genetics and ROSALIND®?
This partnership enhances capabilities in single-cell genomics, making advanced technologies more accessible for life science researchers.
What key technologies are involved in this collaboration?
The collaboration integrates CS Genetics' SimpleCell™ platform with ROSALIND®'s analytical power, aiming to simplify workflows and reduce costs associated with single-cell research.
How does the SimpleCell™ platform benefit researchers?
The SimpleCell™ platform eliminates the necessity for complex, expensive instruments, enabling researchers to undertake larger projects while lowering costs.
Who benefits from this technology?
Biopharma teams and academic researchers benefit significantly by gaining access to tools that facilitate extensive single-cell studies and comprehensive data analysis.
What future developments can be anticipated from this partnership?
We can expect future innovations that will further integrate solutions, enhance collaboration, and improve insights generation across various life science disciplines.
